2seventy bio Inc (TSVT)
4.87
+0.11
(+2.31%)
USD |
NASDAQ |
May 06, 12:47
2seventy bio Cash from Financing (Quarterly): 0.253M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.253M |
| September 30, 2023 | -0.075M |
| June 30, 2023 | 0.128M |
| March 31, 2023 | 127.08M |
| December 31, 2022 | 0.232M |
| September 30, 2022 | 0.175M |
| Date | Value |
|---|---|
| June 30, 2022 | -4.277M |
| March 31, 2022 | 170.10M |
| December 31, 2021 | 186.69M |
| September 30, 2021 | 51.97M |
| June 30, 2021 | 45.12M |
| March 31, 2021 | 71.10M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-4.277M
Minimum
Jun 2022
186.69M
Maximum
Dec 2021
54.04M
Average
22.69M
Median
Cash from Financing (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 14.64B |
| Johnson & Johnson | 546.00M |
| Macrogenics Inc | 0.273M |
| Akebia Therapeutics Inc | -1.29M |
| Tango Therapeutics Inc | 1.467M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -63.60M |
| Cash from Investing (Quarterly) | 47.89M |
| Free Cash Flow | -180.72M |
| Free Cash Flow Per Share (Quarterly) | -1.258 |
| Free Cash Flow to Equity (Quarterly) | -64.67M |
| Free Cash Flow to Firm (Quarterly) | -64.67M |
| Free Cash Flow Yield | -75.34% |